CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-20 | Marshall Patrick Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Share Option (right to buy) | +120,000 | 120,000 | ||
| 2023-07-20 | Lemieux Stephen Chief Financial Officer | Grant or award · Share Option (right to buy) | +75,000 | 75,000 | ||
| 2023-07-20 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Share Option (right to buy) | +120,000 | 120,000 | ||
| 2023-07-20 | Lemieux Stephen Chief Financial Officer | Grant or award · Share Option (right to buy) | +75,000 | 75,000 | ||
| 2023-07-20 | Brooks Michael J President | Grant or award · Share Option (right to buy) | +80,000 | 80,000 | ||
| 2023-07-20 | Marshall Patrick Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | MacDonald Sean Arthur Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | Chypyha Joan Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | OAKES FRANK R. Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | Olson Charles V Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | Sistilli Carlo Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-01-10 | van der Velden Peter 10% owner | Sale | −139,450 | $2.63 | $367K | 1,625,133 |
| 2023-01-10 | van der Velden Peter 10% owner | Sale | −12,895 | $2.63 | $34K | 150,275 |
| 2023-01-09 | van der Velden Peter 10% owner | Sale | −132,845 | $2.66 | $354K | 1,764,583 |
| 2023-01-09 | van der Velden Peter 10% owner | Sale | −12,284 | $2.66 | $33K | 163,170 |
| 2022-11-02 | Brooks Michael J President | Grant or award | +4,239 | $1.13 | $5K | 30,480 |
| 2022-11-02 | Brooks Michael J President | Grant or award · Common Share Warrants (Right to Buy) | +2,119 | 2,119 | ||
| 2022-11-02 | Brooks Michael J President | Grant or award · Common Share Warrants (Right to Buy) | +2,119 | 2,119 | ||
| 2022-11-02 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award | +8,888 | $1.13 | $10K | 10,715 |
Page 5 of 15 · 284 trades